Select Page



  • 1993 –  the U.S Food and Drug Administration (FDA) approved Johnson & Johnson’s Risperdal® for schizophrenia in adults and for short-term treatments for conditions associated with bipolar I disorder.
  • 1996 – approximately a million prescriptions for Risperdal® were issued.
  • 2002 – Janssen Pharmaceuticals issues warning to Canadian doctors regarding an increased risk of stroke associated with Risperdal® in elderly dementia patients. Risperdal® is allegedly responsible for at least 37 cases of stroke-like incidents, including 16 deaths.
  • 2003 – Janssen Pharmaceuticals issues same warning to American doctors.
  • 1993- 2004 – Allegations that Johnson & Johnson illegally marketed Risperdal® before obtaining FDA approval arise.
  • 2005 – Black box warning label (the most severe warning a medication can have) was required by the FDA. Risperdal® reaches $2.1 billion in annual sales as doctors continue to prescribe drugs for non-approved (off-label) use, which include treatments for conditions such as autism, Alzheimer’s and ADD.
  • 2006– a clinical study revealed links to Risperdal® and the risk of developing gynecomastia, a condition that causes male breast tissue enlargement.
  • 2007 – FDA approved Risperdal® for schizophrenia in teenagers.
  • 2012 – Johnson & Johnson settles claims of misconduct for $181 million in Kentucky, $159 million in Texas, and $5.9 million in Montana (2 years later in 2014). These were a result of lawsuits alleging Johnson & Johnson concealed dangerous side effects of Risperdal
  • 2014 – new study links the increased risk of developing gynecomastia in adult men after taking Risperdal®

Many have already received hundreds of thousands of dollars.


Johnson & Johnson plead guilty to criminal charges and paid a $2.2 Billion settlement to the US government to resolve charges of its illegal promotion of Risperdal® to children and the elderly. Evidence shows Risperdal’s® manufacturer deliberately misled the medical community about the extent of the risk of young men developing gynecomastia. Risperdal® lawsuits are currently being filed and Johnson & Johnson continues to face claims related to this condition. If you or a loved one were affected by Risperdal®, you may be entitled to compensation.

We Can Help You

If you or a loved one have suffered because of a dangerous drug or device, or have been injured, you may be entitled to financial compensation. Recovery may include compensations for your medical bills, pain and suffering, and loss of wages. Please contact Avram Blair & Associates, P.C. immediately. We will spend time evaluating any potential claims. Call us toll-free (888) 384-5745 or fill out the form below and a Legal Intake Specialist will reach out to you.

Clients Come First

We believe people deserved to be treated with respect and attention. We offer free initial consultations with an experienced attorney. Phone calls are always returned promptly, and we always update our clients on the status of his or her case.